Discovery of novel transcriptional and epigenetic targets in APL by global ChIP analyses: Emerging opportunity and challenge
- PMID: 20159604
- DOI: 10.1016/j.ccr.2010.01.012
Discovery of novel transcriptional and epigenetic targets in APL by global ChIP analyses: Emerging opportunity and challenge
Abstract
Identifying transcriptional program(s) deregulated by oncoproteins is key to understanding the molecular basis of the disease. In this issue of Cancer Cell, two studies by Martens et al. and Wang et al. provide global blueprints for transcriptional targets and epigenetic modifications mediated by PML-RARalpha in acute promyelocytic leukemia.
2010 Elsevier Inc. All rights reserved.
Comment on
-
PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia.Cancer Cell. 2010 Feb 17;17(2):173-85. doi: 10.1016/j.ccr.2009.12.042. Cancer Cell. 2010. PMID: 20159609
-
PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia.Cancer Cell. 2010 Feb 17;17(2):186-97. doi: 10.1016/j.ccr.2009.12.045. Cancer Cell. 2010. PMID: 20159610
Similar articles
-
C/EBPα is indispensable for PML/RARα-mediated suppression of long non-coding RNA NEAT1 in acute promyelocytic leukemia cells.Aging (Albany NY). 2021 Apr 26;13(9):13179-13194. doi: 10.18632/aging.203000. Epub 2021 Apr 26. Aging (Albany NY). 2021. PMID: 33901013 Free PMC article.
-
Phase separation of PML/RARα and BRD4 coassembled microspeckles governs transcriptional dysregulation in acute promyelocytic leukemia.Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2406519121. doi: 10.1073/pnas.2406519121. Epub 2024 Aug 13. Proc Natl Acad Sci U S A. 2024. PMID: 39136995 Free PMC article.
-
PML/RARa blocks the differentiation and promotes the proliferation of acute promyelocytic leukemia through activating MYB expression by transcriptional and epigenetic regulation mechanisms.J Cell Biochem. 2019 Feb;120(2):1210-1220. doi: 10.1002/jcb.27077. Epub 2018 Oct 18. J Cell Biochem. 2019. PMID: 30335887
-
The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.Leuk Lymphoma. 2004 Apr;45(4):639-48. doi: 10.1080/10428190310001609933. Leuk Lymphoma. 2004. PMID: 15160934 Review.
-
Understanding the molecular pathogenesis of acute promyelocytic leukemia.Best Pract Res Clin Haematol. 2014 Mar;27(1):3-9. doi: 10.1016/j.beha.2014.04.006. Epub 2014 Apr 13. Best Pract Res Clin Haematol. 2014. PMID: 24907012 Review.
Cited by
-
The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA.J Cell Biol. 2023 Apr 3;222(4):e202201027. doi: 10.1083/jcb.202201027. Epub 2023 Feb 28. J Cell Biol. 2023. PMID: 36880596 Free PMC article.
-
Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: a TRAnsition to targeted therapies.Br J Cancer. 2015 Feb 3;112(3):413-8. doi: 10.1038/bjc.2014.374. Epub 2014 Sep 23. Br J Cancer. 2015. PMID: 25247321 Free PMC article. Review.
-
Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics.Mol Syst Biol. 2011 Oct 11;7:538. doi: 10.1038/msb.2011.73. Mol Syst Biol. 2011. PMID: 21988834 Free PMC article.
-
Acute promyelocytic leukemia (APL): a review of the literature.Oncotarget. 2020 Mar 17;11(11):992-1003. doi: 10.18632/oncotarget.27513. eCollection 2020 Mar 17. Oncotarget. 2020. PMID: 32215187 Free PMC article. Review.
-
PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways.J Cell Biol. 2025 Jun 2;224(6):e202407133. doi: 10.1083/jcb.202407133. Epub 2025 Apr 16. J Cell Biol. 2025. PMID: 40239066 Free PMC article.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources